Show
Sort by
-
- Journal Article
- A1
- open access
Whole genome sequencing and inheritance-based variant filtering as a tool for unraveling missing heritability in pediatric cancer
-
- Journal Article
- A1
- open access
The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples
-
Efficacy of interdisciplinary rehabilitation in child cancer survivors : impact on physical fitness, fatigue and body composition after 1‐year follow‐up
-
- Conference Paper
- C3
- open access
Predicting outcomes with circulating adrenergic neuroblastoma mRNAs in children with relapsed and refractory neuroblastoma : a BEACON-Neuroblastoma biomarker study
-
Minimally invasive classification of pediatric solid tumors using reduced representation bisulfite sequencing of cell-free DNA : a proof-of-principle study
-
GATA2 deficiency and haematopoietic stem cell transplantation : challenges for the clinical practitioner
-
Minimally invasive classification of pediatric solid tumors using reduced representation bisulfite sequencing of cell-free DNA
-
Optimizing care for high-risk neuroblastoma patients treated with dinutuximab : challenges for the multidisciplinary team
-
In vitro characterization of hippo signaling in hematological childhood malignancies
-
Severe phototoxicity associated with concomitant use of methotrexate and voriconazole, an overlooked drug-drug interaction
-
- Journal Article
- A1
- open access
The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children : a review
-
Reintegration into school of childhood brain tumor survivors: a qualitative study using the International Classification of functioning, disability and Health - Children and Youth framework
-
- Journal Article
- A1
- open access
The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness
-
Attending school after treatment for a brain tumor : experiences of children and key figures
-
Combined use of ruxolitinib and sirolimus : increased monitoring of triglycerides required
-
Drug shortages in a pediatric stem cell transplantation ward : challenges and implications : a 5-year bilan
-
Pinpointing a potential role for CLEC12B in cancer predisposition through familial exome sequencing
-
SOX11 as mediator of the adrenergic cell state in NB
-
The strategic plan for paediatric cancer treatment in Belgium
-
ALK positively regulates MYCN activity through repression of HBP1 expression
-
- Miscellaneous
- open access
Minimally invasive classification of pediatric solid tumors using reduced representation bisulfite sequencing of cell-free DNA : a proof-of-principle study
-
GATA2 deficiency and hematopoietic stem cell transplantation : challenges for the clinical practitioner
-
Risk stratification of high-risk metastatic neuroblastoma : a report from the HR-NBL-1/SIOPEN study
-
Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis
-
Non-invasive differential diagnosis of neuroblastoma with other paediatric solid tumors using methylation profiling of circulating cell-free DNA
-
Drug-drug interaction related to the use of pipamperon and ondansetron in a child treated for leukemia
-
Predisposing mutations in hippo signaling reveal an actionable target in Burkitt lymphoma
-
- Journal Article
- A1
- open access
Genes at the crossroad of primary immunodeficiencies and cancer
-
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN) : a multicentre, randomised, phase 3 trial
-
Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients
-
Circulating microRNA biomarkers for metastatic neuroblastoma
-
Non-invasive differential diagnosis of neuroblastoma with other paediatric solid tumors using methylation profiling of circulating cell-free DNA
-
Non-invasive differential diagnosis of neuroblastoma with other paediatric solid tumors using methylation profiling of circulating cell-free DNA
-
Iron overload in haematopoietic stem cell transplantation children and relation to organ damage and survival
-
- Journal Article
- A1
- open access
Genomic amplifications and distal 6q loss : novel markers for poor survival in high-risk neuroblastoma patients
-
Severe anaphylactic reaction following anti-thymocyte globulin administration in a pediatric stem cell transplantation patient
-
- Journal Article
- A1
- open access
Topotecan-vincristine-doxorubicin in stage 4 high risk neuroblastoma patients failing to achieve a complete metastatic response to rapid COJEC : a SIOPEN study
-
Shallow whole genome sequencing on circulating cell-free DNA allows reliable noninvasive copy-number profiling in neuroblastoma patients
-
SOX11 acts as part of the MYCN-WEE1 regulatory protein complex implicated in neuroblastoma
-
SOX11 acts as part of the MYCN-WEE1 regulatory protein complex implicated in neuroblastoma
-
Shallow whole genome sequencing on circulating cell-free DNA allows reliable non-invasive copy number profiling in neuroblastoma patients
-
The HBP1 tumor suppressor is a negative epigenetic regulator of MYCN driven neuroblastoma through interaction with the PRC2 complex
-
Exome sequencing to identify novel neuroblastoma predisposition genes
-
Identification of genetic aberrations predisposing to familial Burkitt lymphoma using whole genome sequencing
-
E-Learning as a tool for continuing education of nurses in hematopoietic stem cell transplantation
-
Identification of novel, rare markers for poor survival in high-risk neuroblastoma patients by merging and reanalysing existing datasets
-
Genomic amplifications and distal 6q loss are novel markers for poor survival in high-risk neuroblastoma patients
-
Farmaceutische zorg voor pediatrisch hemato-oncologische en stamceltransplantatie patiënten : inventarisatie van ervaringen en noden van officina-apothekers en studenten in Vlaanderen
-
Diplopia as presenting sign of Turcot syndrome
-
The ETV5 oncogene is a target of activated ALK signaling in neuroblastoma